Novo Nordisk A/S (NYSE:NVO)

Delayed Data
As of Jul 01
 +0.16 / +0.14%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 123.24, with a high estimate of 144.36 and a low estimate of 75.43. The median estimate represents a +10.44% increase from the last price of 111.59.

Analyst Recommendations

The current consensus among 30 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -5.11%
Growthannually 7.56%


Growthquarterly -2.78%
Growthannually 12.33%
Key to the earnings and sales forecast charts.